Rate My Professor Linda Denehy

Denehy's research specializations encompass acute care prehabilitation and rehabilitation in oncology, perioperative medicine, and critical care, emphasizing the role of exercise, physical activity, and rehabilitation to improve patient outcomes for individuals with cancer and survivors of critical illness. She leads the CanRex research group and has secured over AUD 22 million in grants as chief investigator, including NHMRC-funded randomized controlled trials. Her scholarly output exceeds 250 publications and 40 invited papers, with key contributions such as "Standards for reporting research methods, interventions, and Outcomes in Surgical Prehabilitation studies (SOS-Prehab)" (British Journal of Surgery, 2026), "Prehabilitation Practices for Patients Undergoing Cancer Surgery—An International Survey" (World Journal of Surgery, 2026), "Expert Consensus on Self-Reported Physical, Nutritional, and Psychological Screening Tools for Prehabilitation in Gastrointestinal Cancer Surgery: An International Delphi Study" (Annals of Surgical Oncology, 2026), and guidelines for rehabilitation in critical care. Denehy serves on editorial boards for Physiotherapy Research International, Physical Activity, Exercise and Cancer Journal, and Current Oncology. Her influence is evident in international collaborations with institutions in the UK, USA, and Vietnam, over 50 invited presentations, and major honors including election as a Fellow of the Australian Academy of Health and Medical Sciences (2024), designation as a highly cited researcher by Clarivate (2024), and ranking in the top 0.1% of global rehabilitation experts by Expertscape (2020).